EP1409742A2 - Kit de test pour determiner la presence de souches escherichia coli enterohemorrhagiques (ehec) - Google Patents
Kit de test pour determiner la presence de souches escherichia coli enterohemorrhagiques (ehec)Info
- Publication number
- EP1409742A2 EP1409742A2 EP02762153A EP02762153A EP1409742A2 EP 1409742 A2 EP1409742 A2 EP 1409742A2 EP 02762153 A EP02762153 A EP 02762153A EP 02762153 A EP02762153 A EP 02762153A EP 1409742 A2 EP1409742 A2 EP 1409742A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene
- seq
- test kit
- kit according
- hybridizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 47
- 239000000523 sample Substances 0.000 claims abstract description 63
- 238000012360 testing method Methods 0.000 claims abstract description 59
- 238000001514 detection method Methods 0.000 claims abstract description 49
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 44
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 36
- 230000003321 amplification Effects 0.000 claims abstract description 33
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 21
- 101150104869 SLT2 gene Proteins 0.000 claims abstract description 16
- 101150099846 eaeA gene Proteins 0.000 claims abstract description 13
- 101100257077 Chlamydomonas reinhardtii SLT1 gene Proteins 0.000 claims abstract description 10
- 239000007787 solid Substances 0.000 claims abstract description 7
- 238000009396 hybridization Methods 0.000 claims description 27
- 239000002773 nucleotide Substances 0.000 claims description 25
- 125000003729 nucleotide group Chemical group 0.000 claims description 25
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 22
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 14
- 101000614721 Homo sapiens G protein-activated inward rectifier potassium channel 3 Proteins 0.000 claims description 10
- 239000013642 negative control Substances 0.000 claims description 10
- 101150004681 rfbE gene Proteins 0.000 claims description 10
- 230000004544 DNA amplification Effects 0.000 claims description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 108010091769 Shiga Toxin 1 Proteins 0.000 claims 1
- 102000052505 human KCNJ9 Human genes 0.000 claims 1
- 235000013305 food Nutrition 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 238000007403 mPCR Methods 0.000 description 11
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 101100500479 Hafnia alvei eaeA gene Proteins 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 6
- 101150107911 eae gene Proteins 0.000 description 6
- 230000000369 enteropathogenic effect Effects 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 238000002493 microarray Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 5
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000011896 sensitive detection Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 108010017898 Shiga Toxins Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002875 fluorescence polarization Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000010208 microarray analysis Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000000405 serological effect Effects 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000304 virulence factor Substances 0.000 description 3
- 230000007923 virulence factor Effects 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 2
- 101100378273 Brachyspira hyodysenteriae acpP gene Proteins 0.000 description 2
- 241000588919 Citrobacter freundii Species 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
- 101100504328 Escherichia coli O157:H7 perA gene Proteins 0.000 description 2
- 101000671638 Homo sapiens Vesicle transport protein USE1 Proteins 0.000 description 2
- 101100098690 Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) hly gene Proteins 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- 102100040106 Vesicle transport protein USE1 Human genes 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 101150021605 hlyA gene Proteins 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 101150104300 slt gene Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000033 toxigenic Toxicity 0.000 description 2
- 230000001551 toxigenic effect Effects 0.000 description 2
- 241000588732 Atlantibacter hermannii Species 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241000588731 Hafnia Species 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000208822 Lactuca Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 1
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 229940094991 herring sperm dna Drugs 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Definitions
- EHEC enterohaemorrhagic Escherichia coli strains
- the invention relates to a test kit for the detection of enterohaemorrhagic Escherichia coli strains (EHEC).
- EHEC enterohaemorrhagic Escherichia coli strains
- EHEC Escherichia coli
- Enterohemorrhagic strains of Escherichia coli have been used as food pathogens in the past few years mainly in the USA, but also in some other countries, by causing sporadic, but often dramatic, and more and more frequent occurrences since 1993 Outbreaks of illnesses attracted attention. Infections occurred primarily through the consumption of meat that was not fully roasted (hamburgers), but also through the consumption of raw milk, yoghurt, sausage, apple cider, lettuce, vegetables or seedlings.
- enterohaemorrhagic E. coli infection ranges from watery to bloody diarrhea to kidney damage such as hemolytic uraemic syndrome (HUS), which may lead to death (Griffin, PM, and Tauxe, RV (1991) : The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome. Epidemiol Rev 13: 60-98). Naturally, children, old people and people with immunodeficiency are particularly at risk.
- HUS hemolytic uraemic syndrome
- Enterohaemorrhagic E. coli is usually detected using classic microbiological, biochemical and serological methods (smear on plate, biochemical characterization, agglutination tests, enzyme-linked immunosorbent assay - ELISA) and cell culture methods (e.g. toxin test with Vero cells). Recently, however, detection using modern molecular biological or immunological methods has become increasingly important (Paton, AW, and Paton, JC (1998): Detection and Characterization of Shiga Toxigenic Escherichia coli by Using Multiplex PCR Assays for stxj, stx 2 , eaeA , Enterohemorrhagic E.
- enterohaemorrhagic E. coli strains have some genetic peculiarities that distinguish them from non-pathogenic E. coli strains, they can be specifically detected using molecular biological methods that use these differences.
- EHEC The most important genes typical for EHEC are the toxin genes SLT1 and SLT2 and their variants. Their gene products are largely responsible for the symptoms of an infection with EHEC. Another important gene for a pathogenicity factor of EHEC is the eaeA-Gcn. Since the vast majority of epidemics are caused by EHEC strains of the serotype O157: H7, the detection of this type is particularly important. Genes that are characteristic of this serotype are, for example, the genes rfl> E, a gene from the biosynthetic pathway of the O157 antigen, vm ⁇ fliC, the gene for the H7 antigen. At least the two genes for the toxins SLT1 and SLT2 and the 0157-specific gene rfbE are important for a test for routine food testing in order to clearly identify the dangerous pathogens as EHEC.
- the object of the invention is to provide a test instrument with which the genes required for the detection of enterohaemorrhagic Escherichia coli strains or the serotype 0157 can be detected in a single reaction without major expenditure of equipment and time.
- a control should be included in order to check the performance of the test.
- the use of mutagenic or toxic substances should be avoided in this detection.
- the aim is to provide a reliable tool for routine analysis in the quality control of food but also for the characterization of unknown E. coli strains isolated from any source.
- the aim is to have a test instrument that enables even simply equipped laboratories to prove EHEC within a working day in the shortest possible time, with little hands-on time and without expensive equipment.
- test kit which each has a pair of primers for amplifying at least a part of the SLT1 gene, the SLT2 gene, of the rfbE gene, the e ⁇ -4 gene and a control gene in a single reaction and each contain both an oligonucleotide as a capture probe and an oligonucleotide as a detector probe for hybridization of the amplificates obtained with the primers at room temperature, all capture probes on a common solid surface are immobilized and the detector probes are provided with a visually detectable marking.
- the described molecular biological detection of EHEC by means of the test kit according to the invention offers significant advantages. Since there is neither a 100% reliable selection medium nor a clear biochemical test for EHEC, detection using microbiological, biochemical and serological methods is difficult. Other bacterial genera such as Escherichia hermannii or Hafnia spp. have, for example, a similar biochemical phenotype as O157: H7, or there are often cross-reactions of anti-O157 sera with other bacteria such as Citrobacter freundii or Yersinia enterocolitica.
- Int J Food Microbiol 67: 71-80 is based on the fact that for the implementation of the detection reaction and for the Evaluation of the result requires no expensive special equipment such as microarray scanners and image processing systems or special software, hybridization cassettes or hybridization ovens, since the hybridization takes place at room temperature and the evaluation is carried out with the naked eye.
- Another advantage is the use of capture probes in combination with directly labeled detection probes, so that there is a good specificity from the outset, which may only be guaranteed for microarrays by using at least two capture probes per amplificate (Chizhikov, V. et al, supra ).
- a purification of amplificates or a removal of non-incorporated labels, as is essential when using fluorescence-labeled primers or nucleotides in microarrays, is in the the use of the test kit according to the invention is also not necessary, which reduces hands-on time and material consumption.
- test kit is its exceptional sensitivity compared to other existing molecular biological detection methods for EHEC.
- Fratamico et al. J Food Prot 63 (8): 1032-1037
- a multiplex PCR with 5 genes from EHEC with which a sensitivity of 1 cfu / g food (prepared) could be achieved, namely with an enrichment time of 12 hours, testing of a single strain and using agarose gel electrophoresis instead of hybridization.
- hybridization not only increases the sensitivity of a molecular biological test by signal amplification during detection, but also the specificity.
- the increased number of primers used can lead to unspecific reactions which lead to unspecific bands in gels and can severely impair test interpretation (Chizhikov, V., Rasooly, A., Chumakov, K., and Levy , DD (2001): Microarray analysis of microbial virulence factors. Appl. Environments. Microbiol. 67 (7): 3258-3263).
- German standard DIN10134 "General process-specific requirements for the detection of microorganisms with the polymerase chain reaction (PCR) in food” stipulates, for example, that a PCR result must be verified by hybridization or sequencing. Occurring bands of the apparently correct size can Using agarose gel electrophoresis alone leads to false positive results, however, many molecular biological methods for the detection of EHEC do not meet the above-mentioned condition, but only use agarose gels to evaluate a test result (JP-A - 2001-095576; Hu, Y, Zhang, Q.
- test kit The combination of pre-enrichment, DNA amplification and detection by the test kit according to the invention also allows routine laboratories equipped as standard to quickly and reliably detect EHEC. Only a thermal cycler and a shaker are required on additional equipment.
- a preferred embodiment of the test kit is characterized in that the primer pair for the amplification of a part of the SLT1 gene has the nucleotide sequences SEQ ID NO: 1 and SEQ ID NO: 2.
- the capture probe for hybridizing the SLT1 gene amplificate preferably has the nucleotide sequence SEQ ID NO: 3.
- the nucleotide sequence of the detector probe is preferably SEQ ID NO: 4.
- a further preferred embodiment of the test kit is characterized in that the primer pair for the amplification of a part of the SLT2 gene has the nucleotide sequences SEQ ID NO: 5 and SEQ ID NO: 6.
- the capture probe for hybridizing the SLT2 gene amplificate preferably has the nucleotide sequence SEQ ID NO: 7.
- the nucleotide sequence of the detector probe is preferably SEQ ID NO: 8.
- test kit is characterized in that the primer pair for the amplification of part of the r ⁇ E gene has the nucleotide sequences SEQ ID NO: 9 and SEQ ID NO: 10.
- the capture probe for hybridizing the rfbE gene amplificate preferably has the nucleotide sequence SEQ ID NO: 11.
- the nucleotide sequence of the detector probe is preferably SEQ ID NO: 12.
- test kit is characterized in that the primer pair for the amplification of a part of the eaeA gene has the nucleotide sequences SEQ ID NO: 13 and SEQ ID NO: 14.
- the capture probe for hybridizing the ea ⁇ gene plicate preferably has the nucleotide sequence SEQ ID NO: 15.
- the nucleotide sequence of the detector probe is preferably SEQ ID NO: 16.
- Yet another preferred embodiment of the test kit is characterized in that the human KCNJ9 gene is provided as the control gene.
- the pair of primers for amplifying part of the human KCNJ9-GG ⁇ .S preferably has the nucleotide sequences SEQ ID NO: 17 and SEQ ID NO: 18.
- the capture probe for hybridizing the XCNJP gene amplificate preferably has the nucleotide sequence SEQ ID NO: 19.
- the nucleotide sequence of the detector probe is preferably SEQ ID NO: 20.
- test kit is characterized in that at least one oligonucleotide is provided for a hybridization negative control, which is immobilized on a solid surface.
- the negative control can also consist, for example, of a mixture of several random oligonucleotides.
- the oligonucleotides for the hybridization negative control preferably have the nucleotide sequences SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23 and SEQ ID NO: 24.
- a coupling with alkaline phosphatase is preferably provided as the visually detectable marking of the detector probes, which coupling makes hybridization visible by means of enzymatic conversion of organic dyes.
- the resulting double-stranded DNA fragments are then broken down into single strands (denatured), and one of the respective single strands is hybridized with oligonucleotides (capture probes) bound to any solid surface (membrane, microtiter plate, electrode, chip, polystyrene beads or similar) Nucleotide sequences are each complementary to the relevant single strands.
- this complex is hybridized with further suitable oligonucleotides (detector probes) which bind to further complementary sites of the single DNA strands and which are provided with a label which can be detected directly or indirectly (see FIG. 1).
- oligonucleotides detector probes
- Another optical, autoradiographic or electrochemical detection would also be possible.
- the individual preferred DNA sequences (primer pairs) for the amplification of four gene segments characteristic of EHEC and the internal PCR / hybridization positive control were especially designed to be used jointly in a single reaction (multiplex reaction).
- the aim was to form amplification products that were as small as possible and similar in size in order to achieve the highest possible and also similar amplification efficiency for the individual gene segments and the shortest possible reaction time during amplification.
- the preferred DNA sequences for the capture probes bound to the solid surface and for the labeled detector probes were further selected so that for all DNA sequences a specific hybridization and thus also a specific detection under the same conditions, namely at room temperature (20- 35 ° C), is made possible (multiplex hybridization).
- DNA sequences according to claims 2 to 4 have proven to be particularly effective for the amplification and detection of part of the SLT1 gene from EHEC.
- the DNA sequences disclosed in claims 5 to 7 are directed to the amplification and detection of the SLT2 gene which also occurs in EHEC and most of its variants.
- the subjects of claims 8 to 10 form DNA sequences which are suitable for the amplification and for the detection of a part of the rfbE gene from E. coli strains (in particular O157: H7) which have the O157 antigen.
- the oligonucleotides described in claims 11 to 13 are used for the amplification and the detection of a part of the eaeA gene from E. coli strains.
- Claims 15 to 17 describe oligonucleotides for the detection and detection of the human KCNJ9 gene as an internal positive control for the test.
- oligonucleotides as a negative control for hybridization are set out in claim 19.
- Bacterial strains Enterohaemorrhagic Escherichia co / z ' strains come from the American Type Culture Collection (ATCC). Table 1 shows a list of the used Strains and the genes that are present. The strains were kept on plate count agar plates, overnight cultures were prepared in liquid LB medium.
- ATCC American Type Culture Collection
- Target sequences The DNA sequences for SLT, rflE, eaeA and KCNJ9 genes, which were used for the design of suitable oligonucleotides, come from the GenBank database of the NIH (National Institutes of Health, www.ncbi.nlm .nih.gov) and were prepared and analyzed with the help of DNA analysis software such as GeneRunner (www, generunner.com) or PC / Gene (Intelligenetics Inc., Geneva, Switzerland). After multiple sequence comparisons (Higgins, D.G. and Sharp, P.M. (1988): CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73 (1): 237-244), highly conserved areas of the respective genes were selected.
- amplification primers, capture probes and detector probes were then determined (Rychlik, W., Spencer, WJ, and Rhoads, RE: (1990): Optimization of the annealing temperature for DNA amplification in vitro. Nucl. Acids Res. 18 (21) : 6409-6412), taking care that the annealing temperatures of all primers for the multiplex amplification reaction do not differ too much from one another. Attempts were also made to find probes with a melting temperature that was as similar as possible. Thus, a simultaneous detection of all known variants of all relevant genes should be achieved under the same conditions.
- Primer oligonucleotides, capture probes and detector probes The sequences of the primers and probes are given in Table 2 and in the attached sequence listing. In addition to the specific sequence, capture probes have 12 deoxy-thymidines at the 5 'end as "spacers" to the membrane. All oligonucleotides except labeled detector probes were obtained from VBC-GENOMICS Bioscience GmbH (Rennweg 95B, 1030 Vienna, Austria), detector probes were obtained from DNA Technology A / S (Science Park Aarhus, Gustav Wieds Vej 10A, DK-8000 Aarhus, Denmark) and in the described case were coupled with the enzyme alkaline phosphatase (Hermanson, G.
- Meat samples Mashed mixed pork and beef were purchased from a butcher and kept refrigerated until used.
- Bacterial count determination After calibration of the measurement method for all strains used by comparing the results with the results from the plate count method (number of colonies on plates), the bacterial count of the overnight cultures used for inoculation was determined by EHEC using a BacTrac 4100 analysis system (SY -LAB Automatic GmbH, Tullnerbach No 61-65, 3011 Neupurkersdorf, Austria) impedimetrically determined according to the manufacturer's instructions.
- Genomic DNA from EHEC strains was obtained using commercially available spin column kits (NucleoSpin TM Tissue Kit from Macherey-Nagel GmbH & Co.KG, PO Box 10 13 52, D-52313 Düren, Federal Republic of Germany or High Pure PCR Template Preparation kit from Röche Diagnostics GmbH, Engelhomgasse 3, A-1211 Vienna, Austria) isolated from simple overnight cultures. DNA concentrations were determined in a SmartSpec3000 spectrophotometer (Bio-Rad Laboratories Ges.
- the DNA was used for PCR 1 + 9 with water for molecular biology (Sigma,
- thermostable DNA polymerase Saiki, RK, Gelfand, DH, Stoffel, S., Schare, SS, Higuchi, R., Hörn, GT, Mullis, KB, and Erlich, HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491).
- Reaction conditions final concentrations: 1x amplification buffer, 2.5 mM MgCl 2 (both from Qiagen, Max-Volmer-Strasse, D-40724 Hilden, Federal Republic of Germany), nucleotide mix (each 200 ⁇ M dATP, dGTP, dCTP and dTTP or 200 ⁇ M each dATP, dGTP, dCTP and 600 ⁇ M dUTP), each 0.15 ⁇ M SLTl-fl and SLTl-rl, each 1 ⁇ M SLT2-fl, SLT2-r2, RFB-fl, RFB-rl, EAE-fl, EAE-rl , KCN-fl and KCN-rl, 0.7 ng / ⁇ l human DNA (Sigma, Hebbelplatz 7, A-1100 Vienna, Austria, Cat.
- nucleotide mix each 200 ⁇ M dATP, dGTP, dCTP and dTTP or 200 ⁇ M each dATP,
- Hybridization solution (final concentrations): 5xSSC, 0.1% N-lauroylsarcosine, 0.02% SDS, 1% blocking reagent (Röche), 70 pM SLT1-CO, 240 pM SLT2-CO1, 448 pM RFB-CO, 660 pM EAE -COl, 200 pM KCN-CO.
- a mixture of the detection probes was heated at 45 ° C for about 10 minutes before addition to the hybridization solution.
- the strip was then washed twice with at least 2 ml of washing solution (0.1X SSC, 0.1% SDS) at room temperature for at least 7 minutes.
- washing solution 0.1X SSC, 0.1% SDS
- the color reaction is stopped by swirling the strips in distilled water and evaluating the result immediately after the strips have dried.
- Multiplex amplification / hybridization The amplification and hybridization conditions described in the material and methods provided very good results with all samples used. The signals for the individual genes were sufficiently strong and did not differ too much in their intensity. No cross-reactions were found between the different amplificates.
- Random oligonucleotide Table 1 ATCC strains of Escherichia coli used
- Fig. 2 Hybridization of artificially contaminated meat samples
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne un kit de test pour déterminer la présence de souches Escherichia coli entérohémorrhagiques (EHEC), ce kit comprenant deux amorces pour l'amplification d'au moins une partie du gène SLT1, du gène SLT2, du gène rfbE , du gène eaeA et d'un gène de contrôle lors d'une seule réaction. Il contient également une oligonucléotide en tant que sonde de capture et une oligonucléotide en tant que sonde de détection pour l'hybridation des produits d'amplification obtenus avec les amorces à température ambiante, toutes les sondes de capture étant immobilisées sur une surface solide commune et les sondes de détection étant dotées d'un marquage visible. Ce kit de test permet de déterminer la présence de souches Escherichia coli entérohémorrhagiques de manière fiable et simple lors d'une seule réaction.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0117201A AT411832B (de) | 2001-07-26 | 2001-07-26 | Test-kit für den nachweis der bakteriellen gene slt1, slt2 und rfbe |
| AT11722001 | 2001-07-26 | ||
| PCT/AT2002/000222 WO2003010332A2 (fr) | 2001-07-26 | 2002-07-26 | Kit de test pour determiner la presence de souches escherichia coli enterohemorrhagiques (ehec) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1409742A2 true EP1409742A2 (fr) | 2004-04-21 |
Family
ID=3686560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02762153A Withdrawn EP1409742A2 (fr) | 2001-07-26 | 2002-07-26 | Kit de test pour determiner la presence de souches escherichia coli enterohemorrhagiques (ehec) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1409742A2 (fr) |
| AT (1) | AT411832B (fr) |
| WO (1) | WO2003010332A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005005659A1 (fr) * | 2003-07-14 | 2005-01-20 | Statens Serum Institut | Diagnostic d'escherichia coli (dec) et de shigella spp diarrheogenes |
| CN100441696C (zh) * | 2004-10-22 | 2008-12-10 | 中国疾病预防控制中心传染病预防控制所 | 肠出血性大肠杆菌o157:h7菌株的检测方法 |
| CA3226812A1 (fr) * | 2021-07-27 | 2023-02-02 | Gen-Probe Incorporated | Compositions et procedes de detection d'agents pathogenes gastro-intestinaux |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5654417A (en) * | 1995-04-14 | 1997-08-05 | Children's Hospital And Medical Center | Nucleic acid probes for detecting E. coli O157:H7 |
| DE19814828A1 (de) * | 1998-04-02 | 1999-10-07 | Roche Diagnostics Gmbh | Spezifisches und sensitives Nukleinsäurenachweisverfahren |
| FR2777907B1 (fr) * | 1998-04-28 | 2002-08-30 | Pasteur Sanofi Diagnostics | Sequences nucleotidiques pour la detection des escherichia coli enterohemorragiques (ehec) |
| DE19946296A1 (de) * | 1999-09-28 | 2001-03-29 | Roche Diagnostics Gmbh | Multiplex-PCR zum Nachweis von EHEC-Infektionen |
-
2001
- 2001-07-26 AT AT0117201A patent/AT411832B/de not_active IP Right Cessation
-
2002
- 2002-07-26 WO PCT/AT2002/000222 patent/WO2003010332A2/fr not_active Ceased
- 2002-07-26 EP EP02762153A patent/EP1409742A2/fr not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO03010332A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003010332A3 (fr) | 2003-11-06 |
| WO2003010332A2 (fr) | 2003-02-06 |
| ATA11722001A (de) | 2003-11-15 |
| AT411832B (de) | 2004-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU651077B2 (en) | Process for detection of water-borne microbial pathogens and indicators of human fecal contamination in water samples and kits therefor | |
| US6723505B1 (en) | Method for identification of the indicators of contamination in liquid samples | |
| Nocker et al. | Discrimination between live and dead cells in bacterial communities from environmental water samples analyzed by 454 pyrosequencing | |
| US20120288864A1 (en) | Detection of salmonella by real-time multiplex pcr | |
| US6312930B1 (en) | Method for detecting bacteria using PCR | |
| Tantawiwat et al. | Development of multiplex PCR for the detection of total coliform bacteria for Escherichia coli and Clostridium perfringens in drinking water. | |
| Gutierrez et al. | A quantitative PCR‐ELISA for the rapid enumeration of bacteria in refrigerated raw milk | |
| Hofstra et al. | Microbes in food processing technology | |
| Yamazaki et al. | Development of a loop-mediated isothermal amplification assay for sensitive and rapid detection of Campylobacter fetus | |
| Chen et al. | A rapid, sensitive and automated method for detection of Salmonella species in foods using AG‐9600 AmpliSensor Analyzer | |
| Rademaker et al. | Characterization of the diversity of ecologically important microbes by rep-PCR genomic fingerprinting | |
| Abd-El-Haleem et al. | Multiplex-PCR and PCR-RFLP assays to monitor water quality against pathogenic bacteria | |
| EP1366189B1 (fr) | Identification de bacteries pathogenes | |
| Harris et al. | The detection of foodborne pathogens by the polymerase chain reaction (PCR) | |
| Baez et al. | Nonradioactive colony hybridization assay for detection and enumeration of enterotoxigenic Clostridium perfringens in raw beef | |
| AT411832B (de) | Test-kit für den nachweis der bakteriellen gene slt1, slt2 und rfbe | |
| Saint et al. | A PCR test for the identification and discrimination of Legionella longbeachae serogroups 1 and 2 | |
| WO2005035789A1 (fr) | Amorce servant a la detection d'alicyclobacille | |
| KR100248909B1 (ko) | 중합효소 연쇄반응을 이용한 대장균 o157:h7의 다종 유전자 동시검출방법 | |
| DE10214153A1 (de) | Verfahren zum Nachweis von Mikroorganismen mittels in situ-Hybridisierung und Durchflusszytometrie | |
| KR102407237B1 (ko) | 캠필로박터를 선택적으로 구분 검출할 수 있는 리얼-타임 pcr 키트 | |
| Smith et al. | Molecular diagnostics in food safety: rapid detection of food-borne pathogens | |
| EP1772522A1 (fr) | Contrôle de préservation avec des biomarqueurs | |
| Kumar | Modern trends to investigate foodborne Listeriosis | |
| KR20110101612A (ko) | 그람양성 식중독 유발 세균 검출용 올리고뉴클레오타이드 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040114 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| 17Q | First examination report despatched |
Effective date: 20040715 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20051209 |